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ABSTRACT
The 279-bp major breakpoint region (mbr) within the
30-untranslated region (30-UTR) of the BCL2 gene is a
binding site of special AT-rich sequence binding
protein 1 (SATB1) that is well known to participate
in the long-range regulation of gene transcription.
Our previous studies have revealed that the mbr
could regulate BCL2 transcription over a 200-kb
distance and this regulatory function was closely
related to SATB1. This study is to explore the
underlying mechanism and its relevance to cellular
apoptosis. With chromosome conformation capture
(3C) and chromatin immunoprecipitation (ChIP)
assays we demonstrated that the mbr could
physically interact with BCL2 promoter through
SATB1-mediated chromatin looping, which was
required for epigenetic modifications of the
promoter, CREB accessibility and high expression
of the BCL2 gene. During early apoptosis, SATB1
was a key regulator of BCL2 expression. Inhibition
of SATB1 cleavage by treatment of cells with a
caspase-6 inhibitor or overexpression of mutant
SATB1 that was resistant to caspase-6, inhibited
disassembly of the SATB1-mediated chromatin
loop and restored the BCL2 mRNA level in Jurkat
cells. These data revealed a novel mechanism of
BCL2 regulation and mechanistically link SATB1-
mediated long-range interaction with the regulation
of a gene controlling apoptosis pathway for the first
time.
INTRODUCTION
BCL2 proto-oncogene was ﬁrst cloned from the t(14;18)
translocation breakpoint in human follicular B-cell
lymphoma. It is  250kb in length and composed of
three exons and two promoters (1). The BCL2 protein is
a key regulator of apoptosis and is additionally involved
in DNA repair, cell cycle and differentiation control (1–5).
Given its fundamental importance for the cellular fate,
BCL2 expression is ﬁnely tuned by a variety of environ-
mental and endogenous stimuli and regulated at both
transcriptional and post-transcriptional levels. Our
previous report has demonstrated that the major break-
point region (mbr) within the 30-UTR of the BCL2 gene
that is 200-kb downstream of the promoter, is a transcrip-
tional regulatory element and stimulates BCL2 gene
activity (6). The regulatory function of the mbr is closely
related to SATB1 (7). However, the mechanism by which
the mbr distal element executes its long-range regulatory
function remains to be elucidated.
It is increasingly clear that genomic regulation by distal
elements involves the formation of direct physical associ-
ations between distal elements and their target genes with
the intervening chromatin being ‘looped out’ (8–14). In
case of enhancers, chromosomal interaction appears to
be speciﬁc and to require deﬁned proteins to mediate as-
sociation between particular sets of genomic elements
(12,15–18). Many factors, including MAR binding
proteins, transcriptional factors and RNA polymerase
II, have been suggested for roles in the formation of chro-
matin loops (15,19–21). For instance, SATB1-mediated
loop formation is found to be important for the expression
of the cytokine genes, b-globin gene cluster and MHC I
locus (15,22–24). GATA-1 and its cofactor FOG-1 are
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locus control region (LCR) and b-globin promoter (20).
SATB1 is primarily and highly expressed in thymocytes. It
belongs to a class of transcription factors that function as
a landing platform for several chromatin remodeling
enzymes and hence regulates the epigenetic status in a
large chromatin domain (25). Nevertheless, the connection
of SATB1-mediated long-range regulation and expression
of speciﬁc genes controlling apoptosis pathway has not
been established. The mbr is known to be the binding
site of SATB1 (26). The close relation of the mbr regula-
tory function and SATB1 revealed by our previous studies
(7) implies an involvement of SATB1 in the long-range
regulation of the BCL2 gene.
In the present work we focused on the two main issues:
(i) whether the mbr distal element executes its long-range
regulatory function by physically interacting with the
BCL2 promoter through SATB1-mediated chromatin
looping and (ii) what the biological signiﬁcance of the
mbr-BCL2 promoter interaction is. To address these ques-
tions we systematically investigated SATB1-mediated
interaction between the mbr distal element and BCL2
promoter, the correlation of mbr-promoter interaction
with epigenetic modiﬁcations of the promoter, in vivo
and in vitro status of C/EBPb and p300 binding, accessi-
bility of critical transcriptional factor CREB to BCL2
promoter as well as transcription activity of the BCL2
gene in Jurkat cells using chromosome conformation
capture (3C) methodology, chromatin immunopre-
cipitation (ChIP) and electrophoretic gel mobility shift
assay (EMSA). We found that the mbr distal element
physically interacted with the promoter that is 200kb
away, through SATB1-mediated chromatin looping. The
physical interaction between the mbr and the promoter
was required for the epigenetic modiﬁcations of the
promoter, CREB binding and high expression of the
BCL2 gene. Reduced mbr-promoter interaction by
knockdown of SATB1 signiﬁcantly decreased the tran-
scriptional activity of the BCL2 gene and increased cell
apoptosis rates. Inhibition of SATB1 cleavage with
10mM Z-VEID-fmk, a speciﬁc inhibitor of caspase-6 in-
hibited disassembly of the SATB1-mediated chromatin
loop and restored the BCL2 mRNA level in Jurkat cells
in response to apoptotic stimulation. The effect of SATB1
cleavage on BCL2 expression was further conﬁrmed by
overexpression of mutant SATB1 that was resistant to
caspase-6. Our study provides the ﬁrst evidence that the
SATB1-mediated long-range regulation played an import-
ant role in regulation of the BCL2 gene in response to
cellular apoptosis.
MATERIALS AND METHODS
Cell culture and induction of apoptosis
Human T lymphoid cell line Jurkat is a generous gift from
Dr Krontiris’ Laboratory at City of Hope National
Medical Center in Los Angeles, USA. Jurkat cells were
grown in RPMI 1640 medium supplemented with 10%
FBS, 10mM HEPES, 100U penicillin per ml and 10mg
streptomycin per ml. The cells were incubated at 37 Ci n
humidiﬁed atmosphere containing 95% air/5% CO2. For
induction of apoptosis, Jurkat cells were treated with 5mM
camptothecin for 2h and subsequently harvested. The
vehicle control for camptothecin is the equal volume of
DMSO. For protease inhibitor assay, Jurkat cells were
preincubated with 10mM Z-VEID-fmk for 30min.
Apoptosis was then induced by the addition of
camptothecin.
ChIP assay
ChIP assays were performed using the ChIP assay kit es-
sentially as described in the manufacturer (Upstate).
Brieﬂy, Jurkat cells (1 10
7) were ﬁxed in RPMI 1640
medium containing 1% formaldehyde for 10min at
room temperature. After cell lysis, genomic DNA was
sheared into 200–1000bp fragments using Sonics
VCX130 (SONICS). Sheared chromain was incubated
with anti-SATB1 (a generous gift from Dr Krontiris’
Laboratory at City of Hope National Medical Center in
Los Angeles, USA), anti-CREB (Santa Cruz),
anti-Acetyl-H3 (Upstate), anti-Acetyl-H4 antibody
(Upstate) anti-C/EBPb (Santa Cruz), anti-p300 (Santa
Cruz), anti-CBP (Santa Cruz)and IgG (Upstate) overnight
at 4 C, respectively. NaCl was added to the ChIP samples
for 4h at 65 C to reverse the cross-links. To purify the
immunoprecipitated DNA, RNase and proteinase K were
added in order, followed by phenol–chloroform extrac-
tion, ethanol precipitation and resuspension of the DNA
in distilled water. The input genomic DNA and the
immunoprecipitated DNA was then ampliﬁed by PCR
using speciﬁc primers listed in Supplementary Table S1.
The PCR cycling parameters were as follows: 30s at 95 C,
30s at 56 C, 30s at 72 C, for 32 cycles. The PCR products
were subjected to gel electrophoresis, stained with
ethidium bromide and analyzed on Molecular Imager
Gel Doc XR System (Bio-Rad).
Quantiﬁcation of ChIP assay
For quantitative analysis of ChIP products, real-time PCR
(ABI PRISM 7000 system, Applied Biosystems) was
carried out according to TOYOBO manufacturer’s in-
structions using SYBR Green real-time PCR Master
Mix (TOYOBO). Primers designed for speciﬁcally amp-
lifying SBS1, P1 and mbr of BCL2 were listed in
Supplementary Table S1. Annealing temperatures were
as follows: 63 C for SBS1 and mbr amplicons; 65 C for
P1 amplicon. Standard curves for relative quantiﬁcation
were calculated using 1:2, 1:4, 1:8 and 1:16 dilutions of
input samples. All PCR signals from immunoprecipitation
samples were referred to their respective input standard
curve to normalize differences in cell number and primer
efﬁciency. Real-time PCR data were analyzed accord-
ing to the methodology described in a recent report
(27). Ct values were ﬁrst calculated using the
formula: Ct=Ct sample Ct input, from which Ct
(Ct experiment sample Ct negative control) and fold differ-
ence [2
( Ct trememt)/2
( Ct control)] were derived.
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The principle of 3C assay is summarized in Supplementary
Figure S1. The 3C protocol was adapted from Jiang et al.
(2008) (28) and Hagege et al. (29) with modiﬁcations.
Cross-linking was achieved by incubating 1 million cells
in 2ml medium containing 2% formaldehyde for 5min at
room temperature and stopped by adding glycine to
0.125M. Cells were then lysed in 1.25ml lysis buffer
(10mM Tris–HCl at pH 8.0, 10mM NaCl, 0.2% NP-40)
with freshly added protease inhibitors for 60min at 4 C
with rotation. The nuclei were suspended in 1.2  restric-
tion buffer (Buffer 2 for SBS2/mbr or Buffer 3 for SBS1/
mbr, NEB)+0.3% SDS and incubated at 37 C for 1h
with shaking. The SDS was then sequestered by adding
Triton X-100 to 1.8% and incubating at 37 C for another
hour with shaking. Hundred units of the restriction
enzyme (NEB) (AseI for SBS1-mbr, HindIII for SBS2/
mbr) were added for a 22-h digestion. The reaction was
stopped by adding SDS to 1.6% and incubating at 65 C
for 20min. About 2mg of digested chromatin was diluted
in 800ml ligation buffer (NEB). Residual SDS was seques-
tered by adding Triton X-100 to 2% and incubating at
37 C for 1h with shaking. The reaction was then cooled
to 16 C and 2000U of T4 DNA ligase (NEB) were added.
After ligation overnight, the chromatin mixture was
incubated with 100mg/ml proteinase K at 65 C overnight
to reverse crosslinks. RNA was removed by RNase A
(0.5mg/ml) treatment for 30min at 37 C. The 3C sample
was puriﬁed by phenol–chloroform extraction and then
ampliﬁed by PCR using speciﬁc primers listed in the
Supplementary Table S1. The PCR cycling parameters
were as follows: 30s at 95 C, 30s at 56 C/59 C, 30s at
72 C, for 35 cycles. PCR products from both AseI or
HindIII digested crosslinked chromatin without ligation
and non-crosslinked genomic DNA with or without
ligation were used as negative controls. All PCR
products were sequenced.
To normalize primer efﬁciency control PCR templates
were generated by digestion and random ligation of bac-
terial artiﬁcial chromosomes containing BCL2 gene (clone
CTD-2270P21, CTD-3241O8, Invitrogen) or PGK1 gene
(CTD-2255G23, Invitrogen). A total of 5mg of one BAC
clone or equal molar amounts of two BAC clones were
digested with AseI and then ligated at a high DNA
concentration.
Quantitative real-time PCR was performed, in the
presence of SYBR Green, with appropriate primers from
puriﬁed DNA as well as the control template. To accur-
ately determine the DNA concentration of a 3C sample,
20-dilutions of each 3C sample was ﬁrst analyzed by
real-time PCR using SBS1 ChIP primers and the DNA
concentration was calculated according to the standard
curve that was established using reference genomic DNA
with known concentrations. Samples were then subse-
quently adjusted to a concentration of 50ng/ml. For each
primer pair successive 4-fold (PGK1) or 2-fold (BCL2)
dilutions of the random ligation standard were used to
make a calibration curve for determining a relative
quantity of the corresponding ligation product in a 3C
sample. The ligation efﬁciency between the samples was
corrected by the interaction between two AseI fragments
within the ubiquitously expressed PGK1 locus that had
been checked to be transcribed stably in our experiment
systems (Supplementary Tables S2, S3 and Figure S2).
Electrophoretic mobility shift assays
Nuclear extracts were prepared using NE-PER nuclear
and cytoplasmic extraction Reagents (Pierce) following
the manufacturer’s instructions. In brief, Jurkat cells
were harvested and washed with cold PBS. The cell
pellet was suspended in CRE I buffer and incubated on
ice for 10min. Following incubation with CRE II
solution, the preparation was centrifuged at 12000g for
5min. The pellet was treated with nuclear extraction
reagent (NER) with vortexing for 15s every 10min, for
a total of 40min. After centrifugation at 12000g for
10min, the remaining supernatant was the nuclear
extract. The protein concentrations were measured using
a Bio-Rad protein assay.
The electrophoretic mobility shift assays (EMSA) was
performed using a gel shift assay kit following the manu-
facturer’s instructions (Promega Corp.). Oligonucleotide
probes were labeled with [g-
32P] ATP by T4-
polynucleotide kinase (New England Biolabs Ltd,
Beijing, China). A total of 10mg of Jurkat nuclear
extracts were incubated with 0.05pmol of labeled probes
in the gel shift binding buffer for 20min at room tempera-
ture. The samples were separated on a 4% polyacrylamide
gel. Signals were recorded on X-ray ﬁlm. The sequences of
probes were synthesized: 42 mbr-F, 50-TATTTTATGAA
AGGTTTACATTGTCAAAGTGATGAATATGGA-30;
42 mbr-R, 50-TCCATATTCATCACTTTGACAATGTA
AACCTTTCATAAAATA-30; SBS1-F: 50-GATTCCATG
TTTATTAGATTCCATTTTAAAG-30; SBS1-R: 50-CTT
TAAAATGGAATCTAATAAACATGGAATC-30; the
non-speciﬁc competitive probe, SP1-F, 50-ATTCGATCG
GGGCGGGGCGAGC-30 and SP1-R, 50-GCTCGCCCC
GCCCCGATCGAAT-30. For competition experiments,
either speciﬁc or non-speciﬁc oligonucleotide competitor
was added to the binding mixture 10min before addition
of the labeled probe. For supershift experiments, anti-C/
EBPb (Santa Cruz), anti-p300 (Santa Cruz) and
anti-SATB1 (Santa Cruz) were preincubated with the
nuclear extracts in the binding reaction buffer for 40min
at room temperature, respectively.
Isolation of genomic DNA and methylation-speciﬁc PCR
Genomic DNA was isolated using AxyPrep
TM
Multisource Genomic DNA Miniprep kit (Axygen).
Then, 1mg of genomic DNA from each sample was
modiﬁed by sodium bisulﬁte with the CpGenome
TM
DNA Modiﬁcation Kit (Chemicon). The primers for amp-
liﬁcation of methylated DNA were BCL2-MF and
BCL2-MR; the primers for ampliﬁcation of unmethylated
DNA were BCL2-UF and BCL2-UR. All
methylation-speciﬁc PCR (MSP) were performed for 35
cycles with Hot Star Taq DNA Polymerase (Qiagen).
The ﬁnal PCR products of MSP were randomly selected
for sequencing (Invitrogen). CpGenome
TM universal
unmethylated DNA and methylated DNA (Chemicon)
4642 Nucleic Acids Research, 2011,Vol.39, No. 11were used as controls for MSP analysis. The primer se-
quences used in this study were listed in Supplementary
Table S1.
Quantitative methylation speciﬁc real-time PCR
Methylation analysis was performed with real-time PCR
similar to the Methylight technique as described previ-
ously (30). The bisulﬁte-treated genomic DNA obtained
was subjected to real-time PCR analysis. PCR conditions
consisted of an initial denaturation for 1min at 95 C
followed by 40 cycles of denaturation for 15s at 95 C,
following annealing for 1min at 63 C. PCR analysis of
each sample was repeated three times. Data were
analyzed through the comparative threshold cycle (Ct)
method. In order to normalize the input
bisulﬁte-converted DNA, control reactions were carried
out for non-CpG sites of control gene b-Actin, which
has been routinely used in previous reports as a measure
of input bisulﬁte-treated DNA levels (31–33). The b-Actin
primers used for quantitative methylation speciﬁc
real-time PCR (QMSP) are shown in Supplementary
Table S1. For each analysis, the average Ct (Ct BCL2 Ct
Actin) of three experiments was calculated. Then the mean
fold change (2
 Ct) of BCL2 unmethylation status and
variations in Jurkat cells were determined during all
treatments.
Knock down SATB1 by RNAi in Jurkat cells
SATB1-speciﬁc shRNA sequences were synthesized
accordingtotheoneusedinHanetal.(34)andinsertedinto
the pGCsi-H1/Neo/GFP/siNEGative vector (Genscript),
which coexpresses GFP to allow identiﬁcation of
transfection efﬁciency. The SATB1 shRNA sequence was:
SATB1-shRNA 50-GTCCACCTTGTCTTCTCTC-30. The
non-speciﬁc shRNA sequence was: control-shRNA 50-AC
GTGACACGTTCGGAGAA-30 (7). Jurkat cells were
transiently transfected with SATB1 RNAi plasmids or
control plasmids using an electroporator. The extent of
shRNA mediated inhibition of SATB1 and its effect on
BCL2 expression were evaluated by western blot analysis
and RT–RCR respectively.
Western blot analysis
Whole cell extracts were prepared from cells (treated as
described above) using lysis buffer (50mM Tris, pH 7.4,
0.5% NP-40 and 0.01% SDS) containing protease inhibi-
tors. Total protein (20mg) was boiled for 5min in loading
buffer, chilled on ice and then separated on sodium
dodecyl sulfate (SDS)-polyacrylamide gels. Subsequent
to transfer onto PVDF membranes (Bio-Rad), non-
speciﬁc protein interactions were blocked by incubation
in 5% non-fat dry milk in TST buffer (50mM Tris–HCl,
150mM NaCl, 0.05% Tween-20, pH 7.6) at 4 C for 1h.
Membranes were then incubated at 4 C overnight with
anti-SATB1, anti-CREB or anti-b-Actin antibody
(Sigma) in fresh blocking buffer. Horseradish peroxide–
conjugated individual secondary antibody (R&D) was
added for 1h at room temperature. The blot was de-
veloped with ECL reagent (Amersham Biosciences).
Prestained markers (NEB) were used as internal molecular
weight standards.
RNA isolation and RT–RCR
Total RNA was isolated with Trizol reagent (Invitrogen)
according to the manufacturer’s protocol. RNA integrity
was assessed by visualizing the ribosomal bands on a 1%
agarose gel. Finally, cDNA was synthesized from total
RNA (1mg) using AMV reverse transcriptase according
to the manufacturer’s instructions (TOYOBO) and
oligo(dT)15 as the primer. The reactions were incubated
at 42 C for 60min and then stored at  20 C prior to use.
The real-time PCR ampliﬁcation conditions were 50 C for
2min, 95 C for 1min, followed by 40 cycles of denatur-
ation at 95 C for 15s, annealing at 63 C for 1min.
Generation of caspase-6 resistant mutant SATB1
expression vector SATB1-D254A
To prepare the mutant SATB1 expression plasmid
SATB1-D254A that is resistant to caspase-6 cleavage, as-
partate at position 254 in the human SATB1 primary
sequence from SATB1 overexpression plasmid pEGFP-
C1-SATB1 (generous gifts from Dr Krontiris laboratory)
was replaced with alanine using the QuikChange
Site-Directed Mutagenesis Kit (Stratagene). The primer
used for mutagenesis is as follows with the mutated
bases in boldface: mut-F, 50-GATATGATGGTTGAAA
TGGCTAGTCTTTCTGAGCTATC-30. The mutant
plasmid sequence was conﬁrmed by sequencing.
Assay for apoptosis
Apoptosis was estimated by using an Apoptosis Detection
Kit (Keygentech) according to the manufacturer’s instruc-
tion. Brieﬂy, cells were ﬁrst resuspended in binding buffer.
Annexin V-EGFP and propidium iodide (PI) were then
added and incubated at room temperature for 15min in
the dark, followed by assay on FACScan (Becton
Dickinson). The percentage of apoptosis was computed
using CellQuest software (Becton Dickinson).
RESULTS
SATB1 binds to BCL2 promoter and mbr
Our previous work has demonstrated that the long-range
regulatory function of the mbr is closely related to SATB1
that is known to bind to the mbr (6,7). To investigate
whether the regulatory function of the mbr is dependent
on SATB1-mediated modulation of chromatin structure
within the BCL2 gene, we ﬁrst searched for the potential
binding sites of SATB1 in the BCL2 promoter region
using Genomatix Software (http://www.genomatix.de/
index.html). SATB1 prefers sequences that have the char-
acteristic ‘ATC sequence context’, which is enriched in
stretches of DNA sequences containing a mixture of
adenine, thymidine and cytosine (but not guanine), on
one strand (35), although recent studies have suggested a
consensus element that may not follow this rule (36,37).
BCL2 has two promoters, P1 and P2. P1 is located 1386
to 1423bp upstream of the translational start site and is
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1.3kb downstream from P1, only has primary functions
in speciﬁc tissues, such as t(14;18) lymphoma cells and
neuronal cells (38,39). Therefore, in this study we
focused on P1. Using bioinformatic analysis, we found
three sequences, named from SBS1 to SBS3 that might
possibly bind to SATB1 in the 5.1-kb region upstream
of the P1 promoter.
To determine whether SATB1 can bind to these three
sequences in vivo, we performed ChIP assays using an
anti-SATB1 antibody. SBS1 and SBS2 sequences located
 4.1 and  4.7kb relative to the translational start site
(Supplementary Figure S3) were found to be speciﬁcally
immunoprecipitated with anti-SATB1 (Figure 1A and B),
indicating that SATB1 binds to these sequences in vivo.
The ChIP assays on the SBS3 sequence did not reveal
any binding of SATB1 (Figure 1C). ChIP assays targeting
to the mbr were also performed and the binding of SATB1
to the mbr was conﬁrmed in our experimental system
(Figure 1D). The binding of SATB1 to both BCL2
promoter and mbr strongly implied that SATB1 might
mediate an interaction between the mbr element and the
promoter by modiﬁcation of BCL2 chromatin structure.
The mbr physically interacted with the BCL2 promoter
in Jurkat cells
To investigate whether the mbr regulates BCL2 transcrip-
tional activity over the long chromatin distance by phys-
ically interacting with the promoter, 3C technique was
used to analyze the spatial organization of BCL2 in
Jurkat cells. The principle of 3C assay is summarized in
Supplementary Figure S1. For 3C analysis, formaldehyde
is used to crosslink protein–DNA in intact nuclei. The
crosslinked chromatin was then digested by a restriction
enzyme, followed by ligation. If there is apposition
between a remote regulatory sequence and a promoter,
new hybrid fragments containing these two elements are
generated; and carefully designed PCR reactions can be
used to detect and quantify these new combined fragments
(Figure 2A and Supplementary Figure S1). In our experi-
ments AseI or HindIII was used to digest nuclei to
evaluate the interaction between the mbr and SBS1 or
SBS2. PCR bands resulting from the ligation products
indicated that the mbr was linked with SBS1
(Figure 2B), but not with SBS2 (Figure 2C). DNA
sequencing further conﬁrmed that the ligation-dependent
PCR products were derived from ligation of two distal
chromatin fragments (the mbr and SBS1) within the
BCL2 gene (Supplementary Figure S4). PCR was also per-
formed using the BAC clone to ensure the pair of primers
for SBS/mbr worked on the random ligation control
(Supplementary Figure S5). Negative control samples
either from non-crosslinked chromatin or from
cross-linked chromatin that was digested without subse-
quent ligation did not generate any PCR products
(Figure 2B and C). These results clearly indicate that the
mbr and promoter (SBS1) of the BCL2 gene interact with
each other in close proximity via chromatin looping.
SATB1 was required for the mbr-promoter interaction
and BCL2 transcription
To address the question of whether SATB1 is required for
the chromatin loop organization within the BCL2 gene,
we determined the correlation between the binding of
SATB1 to the two distal elements and the SBS1-mbr inter-
action. The level of SATB1 in Jurkat cells was knocked
down with plasmids expressing short hairpin RNAs
(shRNA). Western blot analysis conﬁrmed that shRNA
targeted to SATB1 efﬁciently reduced the expression
level of SATB1 (Figure 3A). Quantitative ChIP assays
revealed that knockdown of SATB1 signiﬁcantly reduced
the occupation of SATB1 on SBS1 and mbr (Figure 3B
and C) and simultaneously decreased the frequency of
interaction between SBS1 and mbr as indicated by quan-
titative 3C assay (Figure 3D). These observations clearly
indicate that SATB1 is a critical mediator of long-distance
interaction between the mbr and the BCL2 promoter.
Figure 1. ChIP analysis of binding of SATB1 at the mbr and the BCL2 promoter region in vivo. The ChIP experiments were performed as described
in the ‘Materials and Methods’ section. The results showed that SATB1 bound to SBS1 (A), SBS2 (B) and mbr (D), respectively, but not to SBS3
(C). The input represented 1% of total chromatin used in immunoprecipitation. Non-speciﬁc IgG was used as a negative control. The PCR products
were visualized by ethidium bromide staining of a 1.5% agarose gel.
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tin looping was involved in transcriptional activity of the
BCL2 gene by examining the correlation of BCL2 mRNA
level and mbr-promoter interaction with RT–PCR and
quantitative 3C assay. Our data showed that a reduction
of the interaction between SBS1 and mbr induced by
knockdown of SATB1 was signiﬁcantly correlated with a
decrease in the BCL2 mRNA level (Figure 3E), suggesting
that SATB1-mediated mbr-promoter interaction was
required for transcriptional activity of the gene.
The SATB1-mediated mbr-promoter interaction
was required for epigenetic modiﬁcations of the
BCL2 P1 region
Active and silent gene expression states can be
characterized by various epigenetic marks, including
histone acetylation and DNA methylation. Acetylated
histone H3 at K9/14 and H4 at K5/8/12/16 are normally
marks for active chromatin (40,41). To evaluate the role
of SATB1-mediated interaction between the mbr and
promoter in epigenetic modiﬁcation of BCL2, we
compared the acetylation status of histones in the P1
region of the BCL2 gene in Jurkat cells in which SATB1
expression was knocked down with that in the control cells
by quantitative ChIP assays using anti-H3 K9/14-Ac and
anti-H4 K5/8/12/16-Ac antibodies in parallel with the
experiments described in Figure 3A–E. As indicated in
Figure 3F and G, the acetylation levels of histones H3
and H4 in the P1 region were dramatically reduced
when SATB1 was silenced using shRNA.
The BCL2 P1 region is extremely GC rich.
Bioinformatic analysis has identiﬁed a CpG island in the
region that contains 147 CpG sites, spanning the region
from  2434 to  1174bp relative to the translation start
site (42). Methylation status examined within this re-
gion was evaluated by quantitative methylation-sensitive
PCR (QMSP). The primers were designed to produce
an unmethylated region from  1552 to  1360bp and
a methylated region from  1549 to  1361bp
(Supplementary Table S1). All samples revealed
unmethylated products, while no methylated products
were detected in Jurkat cells that highly express SATB1.
The unmethylation of the P1 region decreased in Jurkat
cells when SATB1 was knocked down (Figure 3H). These
data clearly demonstrated that SATB1-mediated chroma-
tin looping was required for epigenetic modiﬁcation in the
P1 region.
The SATB1-mediated mbr-promoter interaction enhanced
recruitment of the CREB transcription factor to P1
The cAMP response element (CRE) is one of the major
positive cis-regulators for P1 activity (43). The CREB
transcription factor can function through CRE to
protect diverse cell types from apoptosis by up-regulating
BCL2 (44). To further evaluate the role of SATB1-
mediated special interaction between the mbr and the
BCL2 promoter in regulation of BCL2 expression, the
binding status of the CREB transcription factor at P1
was also examined relative to the chromatin looping in
Jurkat cells. Again, cells in which SATB1 was knocked
down were compared with the control cells. We found
that silencing of SATB1 signiﬁcantly suppressed CREB
binding to P1 even though the level of CREB expression
was not affected (Figure 3I and J), indicating that recruit-
ment of CREB to P1 was primarily dependent on the
SATB1-mediated epigenetic modiﬁcation in the P1
region, particularly the mbr-promoter interaction.
C/EBPb and p300 were associated with both the mbr
and SBS1 in vivo
To identify the enzymes and proteins that are involved in
epigenetic modiﬁcation of the BCL2 promoter related to
SATB1-mediated mbr-promoter interaction, we analyzed
the mbr element and BCL2 promoter region using
Genomatix Software (http://www.genomatix.de/index
.html). A C/EBPb consensus sequence was found on the
Figure 2. 3C Analysis of the interaction between the mbr and the
BCL2 promoter region in vivo. The scheme of BCL2 gene with the
positions of restriction sites and positions of primers was indicated
(A). The 3C experiments were performed as described in the
‘Materials and Methods’ section. Brieﬂy, formaldehyde was used to
crosslink protein–DNA interactions in intact nuclei. The crosslinked
chromatin was then digested by AseI (B) or HindIII (C), followed by
ligation. Physical interaction between mbr and SBS1 or SBS2 was then
determined by speciﬁc PCRs that detected hybrid fragments containing
either mbr/SBS1 sequences or mbr/SBS2 sequences. 3C data
demonstrated that the mbr speciﬁcally interacted with SBS1 (B, up
panel), but not with SBS2 (C, up panel). PCR products from AseI
(B) or HindIII (C) digested crosslinked chromatin without ligation
and non-crosslinked genomic DNA with or without ligation were
used as negative controls. The bands shown in the bottom panels of
B and C represented the PCR products from genomic DNA that was
not cut by any restriction enzyme, which were used as the loading
control.
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overlapping with the SATB1 binding consensus in the
mbr. However, no C/EBPb consensus was identiﬁed at
the SBS1. As CBP/p300 are well established coactivators
for both C/EBPb (45) and SATB1 (46,47) and possess
HAT function (48,49), we ﬁrst determined whether CBP/
300 and C/EBPb could bind to the mbr element by ChIP
assay using anti-CBP, anti-p300 and anti-C/EBPb
antibodies, respectively. Our data showed that the mbr
sequence was speciﬁcally immunoprecipitated with
anti-p300 and anti-C/EBPb, but not with anti-CBP
antibody (Figure 4A), suggesting that p300 and C/EBPb
were speciﬁcally associated with the mbr and formed a
complex with SATB1 in vivo.
We further performed ChIP assay to examine whether
p300 and C/EBPb associate with SBS1 that contains no C/
EBPb binding consensus. The experimental data showed
that SBS1 was speciﬁcally immunoprecipitated either by
C/EBPb or by p300 (Figure 4B), suggesting these two
proteins could be recruited to SBS1 by SATB1 to form a
complex in vivo.
C/EBPb and p300 were associated with the mbr but not
with the SBS1 in vitro
To evaluate the association of C/EBPb and p300 with the
mbr and SBS1 in vitro, in which no chromatin loop struc-
ture exists, EMSA experiment was performed using a
42-bp sequence from the mbr (42mbr) as a probe that
containing both the SATB1 binding site and the predicted
C/EBPb binding consensus. Several bands were formed
when Jurkat nuclear extract was incubated with
32P-labeled 42 mbr probe (Figure 4C, lane 2). The bands
were successfully competed by 100-fold molar excess of
unlabeled 42 mbr cold probe, but not by cold SP1
control consensus sequences (Figure 4C, lanes 3 and 4),
conﬁrming the speciﬁc binding of the protein complexes to
the 42 mbr probe. One of the protein complexes was
supershifted by preincubating the nuclear extract with
increasing amount (2, 6 and 10mg) of anti-C/EBPb and
anti-p300, respectively (Figure 4C, lanes 5–10), indicating
that C/EBPb and p300 bind to the 42-bp mbr region
in vitro. Increasing amount of anti-SATB1 (2, 6 and
10mg) was added to the gel shift reactions as a positive
control (Figure 4C, lanes 11–13). Interestingly, the
supershifted bands resulted from addition of anti-C/
EBPb, anti-p300 and anti-SATB1 occurred at the same
position above the fourth protein complex (indicated,
Figure 4C, lanes 7, 10 and 13), implying that C/EBPb,
p300 and SATB1 can form the same protein complex
that binds to the mbr element in vitro.
We then checked whether C/EBPb, p300 and SATB1
can form a protein complex at the SBS1 by EMSA using
SBS1 consensus as a probe. With a competition experi-
ment, we identiﬁed two protein complexes formed at
SBS1 (Figure 4D, lanes 1–4). The complex 1 was
supershifted when increasing amount of anti-SATB1
(2, 6 and 10mg) was added to the binding reaction
system (Figure 4D, lanes 5–7). In contrast no supershifted
Figure 3. The Association of SATB1 with the chromatin-loop organization and transcription of BCL2 in Jurkat cells. (A) Western blot analysis of
SATB1 in Jurkat cells transiently transfected with control-shRNA or SATB1-shRNA plasmids, respectively indicated that SATB1-shRNA effectively
reduced the SATB1 level in the cells. (B) Quantitative ChIP results obtained from Jurkat cells that were transiently transfected with control-shRNA
or SATB1-shRNA plasmids showed that knockdown of SATB1 expression signiﬁcantly reduced the association of SATB1 with SBS1.
(C) Quantitative ChIP results obtained from the same cells described above conﬁrmed that knockdown of SATB1 expression also signiﬁcantly
reduced the association of SATB1 with the mbr. (D) Quantitative 3C assay was performed as described in ‘Materials and Methods’ section in parallel
with the experiments in B and C. The relative crosslinking frequency between the fragments of SBS1 and mbr indicated that knockdown of SATB1
signiﬁcantly suppressed the mbr-SBS1 (promter) interaction. (E) RT–PCR analysis of the BCL2 mRNA from Jurkat cells transfected with either
control-shRNA or SATB1-shRNA. (F, G and I) The histone acetylation and CREB accessibility were analyzed with quantitative ChIP in Jurkat cells
transiently transfected with control-shRNA or SATB1-shRNA plasmids using antibodies against acetylated histone H3 at K9/14 (F), acetylated
histone H4 at K5/8/12/16 (G) and CREB (I). (H) The methylation level of the BCL2 P1 region was evaluated in the Jurkat cells described above
using QMSP. (J) Western blot analysis of CREB in Jurkat cells transiently transfected with control-shRNA or SATB1-shRNA plasmids. The
statistical differences were calculated using t-test. ‘*’ represents P<0.05 and ‘**’ represents P<0.01. The error bars represent standard deviation
(n=3).
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(Figure 4D, lanes 8–10) or anti-C/EBPb (Figure 4D,
lanes 11–13) antibody. These results indicate that C/
EBPb and p300 are not associated with the SBS1
in vitro, although SATB1 binds to the SBS1 under the
same condition.
SATB1 was required for occupancy of C/EBPb and p300
at SBS1 in Jurkat cells
To further investigate whether C/EBPb and p300 could be
recruited to SBS1 by SATB1, ChIP experiments were per-
formed using SATB1 knockdown cells to examine if it
affected the occupancy of C/EBPb and p300 at SBS1.
Speciﬁc SATB1 shRNA plasmids were transiently trans-
fected into Jurkat cells as described above. Western blot
analysis showed that knockdown of SATB1 by RNAi did
not affect expression of C/EBPb and p300 signiﬁcantly
(Figure 5A). However, quantitative ChIP assays revealed
that the occupancy of C/EBPb and p300 at SBS1 was
signiﬁcantly decreased when SATB1 was knocked down
(Figure 5B and C). These data demonstrated that SATB1
was directly involved in recruitment of C/EBPb and p300
at SBS1 locus.
The SATB1-mediated mbr-promoter interaction regulated
response of the BCL2 gene to apoptosis stimulation
BCL2 is a key regulator of apoptosis. To address the issue
whether SATB1-mediated interaction between mbr and
the promoter of the BCL2 is directly involved in
response of the gene to apoptosis stimulation, we
analyzed the change in chromatin looping, histone acetyl-
ation, DNA methylation, CREB recruitment and tran-
scription activity of the gene in parallel in Jurkat cells
treated with camptothecin. Cells were incubated with
5mM camptothecin and harvested after 2h, when early
apoptosis occurred (Supplementary Figure S6). RT–PCR
results showed that camptothecin treatment reduced
the BCL2 mRNA levels by 50% (Figure 6A).
Correspondingly, quantitative 3C assays revealed that
the frequency of interaction between SBS1 and the mbr
(SATB1-mediated chromatin loop) was reduced
(Figure 6B) in camptothecin-treated cells. The diminished
BCL2 chromatin looping was accompanied by reductions
both in CREB recruitment and acetylation of histone H3
and H4 in the P1 region of BCL2 (Figure 6C–E).
Unmethylation of this region slightly decreased in the
treated cells (Figure 6F). Corresponding to these
changes, the level of SATB1 was clearly decreased in the
Figure 4. Analysis of the association of C/EBPb and p300 with the mbr and the SBS1 sequence with ChIP and EMSA. (A) ChIP assay showed
C/EBPb (lane 3) and p300 (lane 4), but not CBP (lane 5), associated with the mbr in vivo. The PCR products ampliﬁed by speciﬁc primers for the
mbr were visualized on 1.5% agarose gel. (B) ChIP analysis showed that C/EBPb (lane 3) and p300 (lane 4), but not CBP (lane 5), associated with
SBS1 in vivo. The DNA immunoprecipitated with different antibodies were ampliﬁed by speciﬁc primers for the SBS1. (C) EMSA demonstrated that
C/EBPb, p300 and SATB1 formed a protein complex at 42mbr. Lane 1: the negative control without cell lysate. Lane 2: protein complexes formed at
42mbr. Lane 3: 100-fold molar excess of the cold 42mbr probe successfully competed with hot 42mbr probe. Lane 4: 100-fold molar excess of the
cold SP1 consensus sequence (the non-speciﬁc probe) failed to compete with the labeled 42mbr that was bound by the protein complexes. Lane 5, 6,
7: the supershift experiment with 2, 6 and 10mg anti-C/EBPb antibody respectively. Lane 8, 9, 10: the supershift experiment with 2, 6 and 10mg
anti-p300 antibody respectively. Lane 11, 12, 13: the supershift experiment with 2, 6 and 10mg anti-SATB1 antibody respectively. The arrow
indicated the bands supershifted from the same DNA–protein complex with addition of three different antibodies. (D) EMSA demonstrated that
SATB1, but not C/EBPb or p300 binding to the SBS1 in vitro. Lane 1: the negative control without cell lysate. Lane 2: protein complexes formed at
SBS1. Lane 3: the bands were successfully competed with 100-folds molar excess of the cold SBS1 probe. Lane 4: 100-folds molar excess of cold SP1
consensus sequence failed to compete with the SBS1 to be bound by the protein complexes. Lane 5, 6, 7: the supershift experiment with 2, 6 and
10mg anti-SATB1 antibody respectively. Lane 8, 9, 10: the supershift experiment with 2, 6 and 10mg anti-p300 antibody respectively. Lane 11, 12, 13:
the supershift experiment with 2, 6 and 10mg anti-C/EBPb antibody respectively. As indicated by the arrow, DNA–protein formation was inhibited
and supershifted by addition of anti-SATB1 antibody, while no blocked or supershifted band was observed with addition of anti-C/EBPb or
anti-p300 antibodies.
Nucleic Acids Research, 2011,Vol.39, No. 11 4647Figure 6. The association between SATB1-mediated chromatin looping and response of the BCL2 gene to apoptosis stimulation. For induction of
apoptosis, Jurkat cells were treated with 5mM camptothecin for 2h and subsequently harvested. The vehicle control for camptothecin is the equal
volume of DMSO. For protease inhibition assay, Jurkat cells were preincubated with 10mM Z-VEID-fmk for 30min and apoptosis was then induced
by addition of camptothecin. (A) RT–PCR analysis of BCL2 mRNA from Jurkat cells described above. (B) Relative crosslinking frequencies between
ﬁxed fragments of SBS1 and mbr were determined by 3C assay in cells described above. (C–E) Quantitative ChIP results from Jurkat cells treated
with camptothecin and the control, using antibodies against CREB (C), acetylated histone H3 at K9/14 (D) and acetylated histone H4 at K5/8/12/16
(E). (F) The methylation level of BCL2 gene P1 region was evaluated by examining the unmethylation status of this region using QMSP. (G) Western
blot analysis of SATB1 from Jurkat cells treated with camptothecin or not. (H and I) Quantitative ChIP results from Jurkat cells with camptothecin
treatment or not, using antibodies against SATB1. The statistical differences between the treatment groups were calculated using t-test. ‘*’ represents
P<0.05 and ‘**’ represents P<0.01.The error bars represent standard deviation (n=3).
Figure 5. Knockdown of SATB1 decreased the occupancy of C/EBPb and p300 at SBS1 in Jurkat cells. Jurkat cells were transiently transfected with
SATB1 RNAi plasmids or control plasmids using an electroporator. Western blot showed that knockdown of SATB1 did not affect expression levels
of C/EBPb and p300 signiﬁcantly (A). Real-time PCR analysis demonstrated that knockdown of SATB1 signiﬁcantly reduced the occupancy of
C/EBPb (B) and p300 (C) at SBS1. The statistical differences were calculated using t-test. *P<0.05 and **P<0.01. The error bars represent
standard deviation (n=3).
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analysis (Figure 6G). Quantitative ChIP assays further
conﬁrmed that less SATB1 occupied the mbr and P1
region (Figure 6H and I), which could explain why
SATB1-mediated chromatin looping was diminished
upon apoptosis induction. It should be pointed out that
genomic integrity was maintained under our experimental
conditions, which was conﬁrmed by the slight increase in
the frequency of the chromatin loop formed between the
mbr and the promoter of the Noxa gene, a pro-apoptotic
gene that located 3.4Mb downstream of the BCL2 gene
(Supplementary Figure S7). These data suggested that the
SATB1-mediated mbr-promoter interaction was directly
involved in regulation of the BCL2 gene in cellular apop-
tosis response.
SATB1 is known to be the target of caspase-6 and is
degraded by this enzyme during early cell apoptosis. To
conﬁrm the functional role of SATB1-mediated chromatin
loop in cell apoptosis, we further examined the effect of
inhibition of SATB1 degradation on the mbr-promoter
interaction and the BCL2 transcriptional activity in
camptothecin-treated cells. Jurkat cells were pretreated
for 30min with 10mM Z-VEID-fmk, an inhibitor of the
caspase 6-like protease that speciﬁcally cleaves SATB1
during early apoptosis (50), prior to the addition of
camptothecin. We found that pretreatment of cells with
10mM Z-VEID-fmk completely inhibited camptothecin-
induced cleavage of SATB1 (Figure 6G). Consequently,
the decrease in BCL2 mRNA levels and the disassembly
of higher-order chromatin structure were reversed in these
cells (Figure 6A and B). As expected, pretreatment with
Z-VEID-fmk also decreased the percentage of apoptotic
cells (Supplementary Figure S6).
The effects caused by inhibition of SATB1 degradation
on the BCL2 activity were further conﬁrmed by the ex-
periment using mutant SATB1 expression vector that was
resistant to caspase-6 cleavage. In this experiment, Jurkat
cells were transfected with a wild-type SATB1 expression
vector (EGFP-SATB1), mutant SATB1 expression vector
(EGFP-SATB1-D254A) and pEGFP-C1 control vector,
respectively, before treatment with camptothecin. As
shown in Figure 7, overexpression of the mutant
undegradable SATB1 almost completely restored BCL2
mRNA levels in Jurkat cells treated by camptothecin for
two hours, while overexpression of the wild-type SATB1
had only slight effect on BCL2 mRNA level under the
same condition (Figure 7B).
DISCUSSION
Regulation of BCL2 gene is of a great interest, given its
fundamental importance for cell fate. In our previous
work, we identiﬁed a new distal regulatory element, the
mbr that is located within 30-UTR of the BCL2 gene. The
mbr element signiﬁcantly enhances the transcriptional
activity of BCL2 promoter (6,7). In the present study we
uncovered a novel mechanism by which the mbr distal
element implemented its activity at the BCL2 promoter.
We have demonstrated: (i) the mbr distal element physic-
ally interacted with the promoter that was 200kb away
through SATB1-mediated chromatin looping. The
SATB1-mediated BCL2 chromatin loop was required for
the epigenetic modiﬁcation, CREB accessibility and high
expression of BCL2 gene. (ii) The SATB1-mediated BCL2
chromatin loop played a critical role in regulation of
BCL2 expression in cellular response to apoptotic
stimulation.
SATB1 has been reported to bind an AT-rich region
immediately downstream of the mbr (26). Our present
study identiﬁed a new SATB1 binding site, SBS1, that
was located 4.1kb relative to the translational start site
of the BCL2 gene by bioinformatic analysis and ChIP
assays. Further evaluation by quantitative ChIP and 3C
assays was conﬁrmed that SATB1 directly bound to the
SBS1 and the distal mbr element with similar dynamics of
assembly. The SATB1 binding to the two elements was
required for the BCL2 chromatin loop formation, as
knockdown of SATB1 expression by RNAi signiﬁcantly
Figure 7. Mutation of SATB1 cleavability restored BCL2 transcrip-
tional activity upon apoptosis stimulation. Jurkat cells were transiently
transfected with the wild-type SATB1 expression vector (pEGFP-C1-
SATB1), mutant SATB1 expression vector (SATB1-D254A, mutated at
caspase cleavage site) and pEGFP-C1 control vector, respectively.
Twenty-four hours after transfection, cells were treated with 5mM
camptothecin for 2h to induce cell apoptosis. (A) Western blot
analysis of SATB1 from Jurkat cells described above and quantitative
analysis. The results conﬁrmed that mutant SATB1 was un-degradable
and wild-type SATB1 could be degraded in Jurkat cells treated with
camptothecin. (B) RT–PCR analysis showed that camptothecin treat-
ment reduced BCL2 mRNA level. Overexpression of mutant SATB1
completely restored the BCL2 expression, while overexpression of
wild-type SATB1 only partially restored BCL2 expression. The statis-
tical differences were calculated using t-test. ‘**’ represents P<0.01.
The error bars represent standard deviation (n=3).
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Jurkat cells, which was accompanied by reductions in
histone acetylation and the BCL2 transcriptional
activity. These data lead us to propose that SATB1
tethers the mbr distal element and the BCL2 promoter
together and mediates the long-range regulatory function
of the mbr and thus is a critical regulator of BCL2 expres-
sion. Our observation that inhibiting SATB1 degradation
with caspase-6 inhibitor reversed disassembly of the BCL2
chromatin loop further supports this idea. SATB1 may
not be the only tie for the mbr-promoter interaction.
However, it is the only linkage for this interaction in
Jurkat cells of expressing high level of SATB1 so far. It
is important to identify more components present in the
protein complexes involved in the mbr-promoter inter-
action. Such studies are underway in our laboratory.
SATB1 belongs to a class of transcription factors that
recruitchromatinremodelingcomplexes toboundsitesand
thereby regulate gene expressions over long distance (51).
The function of SATB1 in gene regulation (up- or
down-regulation)largelydependsontheproteinsitrecruits,
including histone deacetylases and acetyltransferase
(44,51). P300 is a histone acetyltransferase that regulates
transcription via chromatin remodeling (52). It is also
known to be a co-activator for both C/EBPb (45) and
SATB1 (46,47). With ChIP assay we demonstrate that
C/EBPb and p300 form the complex with SATB1 at the
mbr and the SBS1 (promoter) in vivo, where chromatin
loops are allowed to form. However, EMSA assay found
that C/EBPb and p300 only formed the complex with
SATB1 at the mbr, but not at the SBS1 in vitro, where no
chromatin loop was allowed to form. The EMSA experi-
mentaldatawereconsistent withthe bioinformaticanalysis
results. A C/EBPb consensus sequence was found on the
50-boundary of the SATB1 binding site with partially
overlapping with the SATB1 binding consensus in the
mbr, but no C/EBPb consensus was identiﬁed at the
SBS1. The discrepancy in binding patterns of C/EBPb
and p300 in vitro and in vivo had two implications:
(i) C/EBPb and p300 were originally recruited to the mbr
distal element and were brought to the SBS1 (promoter)
through SATB1-mediated chromatin looping, which
resulted in the increase in histone acetylation of the BCL2
promoter. This deduction was supported not only by the
positive correlation of SATB1-dependent mbr-promote
interaction with histone acetylation and DNA
hypomethylation of the BCL2 promoter demonstrated by
our quantitative ChIP and 3C assays (Figures 3, 5 and 6),
but also by our observation that knockdown of SATB1
signiﬁcantly decreased the occupancy of C/EBPb and
p300 at SBS1 (Figure 5); (ii) The recruitment of p300 to
SATB1 targeted genomic site, such as the mbr and SBS1,
might need the help of other proteins, such as C/EBPb.
From this point of view, it is not too surprising to
see why SATB1-mediated chromatin loop (the mbr-
promoterinteraction)wasrequiredfortheepigeneticmodi-
ﬁcations and maximal transcriptional activity of BCL2
promoter.
Emerging evidence strongly suggests that histone modi-
ﬁcations set the state for DNA methylation (53). When
histone is deacetylated, the chromatin remodeling
complex binds and alters the chromatin structure or nu-
cleosome positioning in such a way as to directly facilitate
access of the DNMT to the nucleosomal DNA. The region
is then methylated which locks the chromatin in a silent
mode (54). In this study, the positive correlation of histone
acetylation (histone H3 at K9/14 and H4 at K5/8/12/16)
with DNA demethylation of the BCL2 promoter was con-
ﬁrmed in Jurkat cells where SATB1 was decreased
either by RNAi or by apoptosis-induced cleavage. It is
likely that alteration of histone acetylation induced by
SATB1-mediated chromatin loop affects the methylation
status of the BCL2 promoter by changing the chromatin
structure and blocking the access of the DNMT to the
nucleosomal DNA. Further investigation is required to
prove this proposal.
Our present work is also of great signiﬁcance in view of
the functional role of SATB1-mediated chromatin loop in
BCL2 regulation in cellular response to apoptotic stimu-
lation. SATB1 is known to be the target of caspase-6 in
cell apoptosis (55). During early Jurkat T-cell apoptosis,
SATB1 is ﬁrst removed from the bases of chromatin loop
domains by caspase-6 cleavage, and that these domains
are cleaved and digested further, which eventually disas-
semble higher-order chromatin structure and lead to
nuclear degradation (50). To address the biological signiﬁ-
cance of SATB1-mediated BCL2 chromatin loop in cell
apoptosis, the correlation between SATB1 cleavage and
the long-range regulation of BCL2 during early apoptosis
of Jurkat cells was carefully investigated under the experi-
mental conditions when the integrity of genomic DNA
was maintained. We demonstrated here that SATB1
cleavage beginning at a very early stage of apoptosis
reduced the BCL2 chromatin loop structure by
modulating the association of SATB1 with the mbr and
the promoter, and consequently downregulated BCL2
transcriptional activity. Importantly, the downregulation
of the BCL2 gene induced by SATB1 cleavage occurred
before the genomic DNA was degraded. The integrity of
the genomic DNA was proved by the presence of a 3.4-Mb
intact chromatin loop formed between BCL2 and Noxa
gene conﬁrmed by 3C assay under the same experimental
conditions. Inhibition of SATB1 cleavage by treatment of
cells with caspase-6 inhibitor inhibited disassembly of the
SATB1-mediated chromatin loop and restored BCL2 ex-
pression level. Additionally, overexpression of mutant
SATB1 that was resistant to caspase-6 cleavage com-
pletely reversed the apoptosis-induced reduction of
BCL2 transcription. These data strongly support the
notion that the SATB1-mediated long-range interaction
between the mbr and BCL2 promoter played a critical
role in regulation of the BCL2 transcriptional activity in
cellular response to apoptotic stimulation. An implication
derived from our data is that SATB1-mediated chromatin
conformation changes might be involved in coordination
of genes controlling apoptosis pathway, since SATB1 has
been considered to be a global organizer of gene expres-
sion in T lymphocytes (51). Identiﬁcation of more BCL2
family members that are subjected to SATB1-mediated
long-range regulation and investigation of their transcrip-
tional correlation will provide valuable information for
understanding the mechanisms underlying coordinated
4650 Nucleic Acids Research, 2011,Vol.39, No. 11regulation of apoptosis-responsive genes at the level of
three dimensional chromatin structures.
All together, our present study reveals a novel mechan-
ism by which BCL2 gene is regulated and provides a useful
model for the investigation of the nature of SATB1-
mediated long-range interaction in regulating genes
controlling apoptosis pathway.
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